The results allow us to formulate a preliminary hypothesis that HIF-1α, ANG-2, and IL-1β may be biomarkers characteristic of bladder cancer, having elevated concentrations in patients with that disease. This evidence concerns the gene IL1B and urinary bladder carcinoma.